International consensus on (ICON) pediatric asthma.
International consensus on (ICON) pediatric asthma.
复制标题
DOI:
10.1111/j.1398-9995.2012.02865.x
复制
发表时间:
2012-08
期刊:
影响因子:
12.4
通讯作者:
Zeiger RS
中科院分区:
文献类型:
--
作者:
Papadopoulos NG;Arakawa H;Carlsen KH;Custovic A;Gern J;Lemanske R;Le Souef P;Mäkelä M;Roberts G;Wong G;Zar H;Akdis CA;Bacharier LB;Baraldi E;van Bever HP;de Blic J;Boner A;Burks W;Casale TB;Castro-Rodriguez JA;Chen YZ;El-Gamal YM;Everard ML;Frischer T;Geller M;Gereda J;Goh DY;Guilbert TW;Hedlin G;Heymann PW;Hong SJ;Hossny EM;Huang JL;Jackson DJ;de Jongste JC;Kalayci O;Aït-Khaled N;Kling S;Kuna P;Lau S;Ledford DK;Lee SI;Liu AH;Lockey RF;Lødrup-Carlsen K;Lötvall J;Morikawa A;Nieto A;Paramesh H;Pawankar R;Pohunek P;Pongracic J;Price D;Robertson C;Rosario N;Rossenwasser LJ;Sly PD;Stein R;Stick S;Szefler S;Taussig LM;Valovirta E;Vichyanond P;Wallace D;Weinberg E;Wennergren G;Wildhaber J;Zeiger RS
Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. In order to achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with health care professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate and fine-tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent from chronic treatment. There is a trend towards considering phenotype specific treatment choices; however this goal has not yet been achieved.
登录
查看更多内容
影响因子:
14.2
作者:
Bernstein, DI;Wanner, M;Liss, GM
通讯作者:
Liss, GM
DOI:
10.1164/rccm.200308-1178oc
发表时间:
2004-08-15
影响因子:
24.7
作者:
Bacharier, LB;Strunk, RC;Sorkness, CA
通讯作者:
Sorkness, CA
影响因子:
12.4
作者:
Ballardini, N.;Kull, I.;Wickman, M.
通讯作者:
Wickman, M.
影响因子:
14.2
作者:
Busse, W;Raphael, GD;Rickard, K
通讯作者:
Rickard, K
影响因子:
12.4
作者:
Andrade, W. C. C.;Camargos, P.;Bousquet, J.
通讯作者:
Bousquet, J.